BMS-986036

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BMS-986036, covering 2019-05-09 to 2022-10-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis [Phase 2]

See pricing